BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 31, 2010
View Archived Issues
MerLion Pharmaceuticals discloses novel antibacterial agents
Read More
Novel antiviral compounds disclosed by U.S. scientists
Read More
NeuroSearch claims new ligands of nicotinic acetylcholine and monoamine receptors
Read More
NeuroSearch discovers novel monoamine reuptake inhibitors
Read More
Novel NS5B inhibitors for treatment of HCV infections claimed by Italian scientists
Read More
Single- and repeat-dose studies encourage further evaluation of ACU-4429 in AMD
Read More
Favorable preclinical safety of bispecific MM-111 antibody for HER2-positive solid tumors disclosed
Read More
Promising preclinical safety profile of new tenofovir analogue CMX-157 disclosed
Read More
Novel HIV maturation inhibitor MPI-0461359 developed at Myriad Pharmaceuticals
Read More
Second-generation cholesterol absorption inhibitors discovered at Merck & Co.
Read More
RAMBO; a new oncolytic viral therapeutic approach with potent preclinical activity
Read More
Arrayit appoints DOCRO to facilitate FDA approval of OvaDx ovarian cancer test
Read More
Syngene to collaborate with Endo to develop anticancer molecules
Read More
Cumberland submits Acetadote sNDA for acute liver failure to FDA
Read More
GSK resubmits Avodart sNDA for prostate cancer to FDA
Read More
Cephalon receives complete response letter from FDA for Nuvigil
Read More
Pearl presents phase I data on PT-003 for chronic obstructive pulmonary disease
Read More
FDA accepts for review Savient's resubmitted Krystexxa BLA
Read More
Immunovaccine Technologies begins enrollment in phase I trial of DPX-0907 cancer vaccine
Read More
Trius reports phase I data on intravenously dosed antibacterial torezolid
Read More
Clinical Data reports results of phase I Stedivaze studies
Read More
MMRF grants awards to Intellikine and Tragara for multiple myeloma therapies
Read More
Ascent Therapeutics changes name to Anchor Therapeutics
Read More
Dicerna and Ipsen enter into exclusive research collaboration
Read More
Alcon completes acquisition of Durezol and Zyclorin
Read More